Loading in 2 Seconds...
Loading in 2 Seconds...
Transatlantic Conference Brussels, November 12, 2013 “Time to Rethink our Policy on Drugs - Experiences from Europe and the Americas” Pave l Bem, MD. National Drug Commission, Czech Republic Global Commission on Drug Policy. „ Opportunities and risks stay so close together…“.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Brussels, November 12, 2013
“Time to Rethink our Policy on Drugs -
Experiences from Europe and the Americas”
Pavel Bem, MD.
National Drug Commission, Czech Republic
Global Commission on Drug Policy
stay so close together…“
(United Nations Office on Drug and Crime, 2010)
No effect on supply reduction side
80% vs. 20%
20% vs. 80%
Unintended negative consequences
“Unintended negative consequences”:
Overall cost is to high…
We act only on the “surface” of the problem…
(Latin America + Europe…)
We behave in simplistic way with no respect to human diversity and human rights (Papua, 2003)
Czech Republic case study
Complex Cost and Benefit Analysis
(5 major studies and 20 sub studies):
1. Secondary analysis of school surveys
2. Prevalence study of problem drug use in the CR
3. Economic and social cost of illegal drug use in the CR
4. Qualitative study among illicit drug users
5. Cost and benefit analysis of the implementation of
penalization of possession of illicit drugs for
Not Increase After Introduction of a
Penalty of Possession for Personal Use
Lead to Decriminalization Act 2008
RecommendationsPrague Declaration, 20091.No size fits all2.Realism is the key3.Human rights apply to ill people in particular4.Public health and public safety concerns must not be seen as contradictory5.Evidence based decision only6.Evaluation and monitoring7.Constant and improving mutual information flow
1. War on drugs has failed:Need for “rebalancing action” in drug policies design
2. Need for wider implementation of cost effective public health measures:Harm reduction services especially at areas of high risk
3. Decriminalization of drug possession and drug consumption worldwide
4. Reallocation of drug budget priorities
(Global Commission on Drug Policy: former presidents, prime ministers, UN officials, intellectuals…)
(EU Action Plan on Drugs 2013-2016, action #5]
“Wishful thinking” is still prevailing among many politicians, decision makers as well as media